News
CLPT
13.83
+0.66%
0.09
Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?
NASDAQ · 6d ago
Weekly Report: what happened at CLPT last week (0907-0911)?
Weekly Report · 6d ago
Weekly Report: what happened at CLPT last week (0831-0904)?
Weekly Report · 09/07 10:00
Analysts Conflicted on These Healthcare Names: ClearPoint Neuro (CLPT), Hims & Hers Health (HIMS) and Phreesia (PHR)
TipRanks · 09/03 13:10
Weekly Report: what happened at CLPT last week (0824-0828)?
Weekly Report · 08/31 10:06
Weekly Report: what happened at CLPT last week (0817-0821)?
Weekly Report · 08/24 10:07
Weekly Report: what happened at CLPT last week (0810-0814)?
Weekly Report · 08/17 10:08
Weekly Report: what happened at CLPT last week (0803-0807)?
Weekly Report · 08/10 10:04
Execution Risks Loom Over Clearpoint Neuro’s CAL Preclinical CRO Investment and Future Profitability
TipRanks · 08/05 06:00
ClearPoint Neuro Earnings Call Highlights Growth and Strain
TipRanks · 08/05 00:53
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case
Seeking Alpha · 08/04 21:10
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 08/04 17:05
Crude Oil Down Over 5%; McDonald's Earnings Top Views
Benzinga · 08/04 16:55
Midday Fly By: Palantir, Caterpillar, McDonald’s report Q2 beats
TipRanks · 08/04 16:01
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), ClearPoint Neuro (CLPT) and Keros Therapeutics (KROS)
TipRanks · 08/04 13:50
ClearPoint Neuro price target lowered to $25 from $30 at Lake Street
TipRanks · 08/04 12:46
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 08/04 12:05
Powell Industries Posts Downbeat Q3 Results, Joins Clearpoint Neuro, Ichor Holdings And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Benzinga · 08/04 12:04
ClearPoint Neuro price target lowered to $22 from $25 at Stifel
TipRanks · 08/04 11:02
Why Palantir Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 08/04 08:42
More
Webull provides a variety of real-time CLPT stock news. You can receive the latest news about Clearpoint Neuro Inc through multiple platforms. This information may help you make smarter investment decisions.
About CLPT
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.